Next Article in Journal
Routine Screening for Central and Primary Adrenal Insufficiency during Immune-Checkpoint Inhibitor Therapy: An Endocrinology Perspective for Oncologists
Next Article in Special Issue
Triple-Negative Breast Cancer: A Review of Current Curative Intent Therapies
Previous Article in Journal
Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention
Previous Article in Special Issue
A Review of Trastuzumab Biosimilars in Early Breast Cancer and Real World Outcomes of Neoadjuvant MYL-1401O versus Reference Trastuzumab
 
 
Review

Article Versions Notes

Curr. Oncol. 2022, 29(7), 4647-4664; https://doi.org/10.3390/curroncol29070369
Action Date Notes Link
article pdf uploaded. 1 July 2022 12:19 CEST Version of Record -
article xml file uploaded 1 July 2022 14:53 CEST Original file -
article xml uploaded. 1 July 2022 14:53 CEST Update https://www.mdpi.com/1718-7729/29/7/369/xml
article pdf uploaded. 1 July 2022 14:53 CEST Updated version of record https://www.mdpi.com/1718-7729/29/7/369/pdf
article html file updated 1 July 2022 14:54 CEST Original file -
article html file updated 12 August 2022 23:46 CEST Update https://www.mdpi.com/1718-7729/29/7/369/html
Back to TopTop